Pharming (PHAR) Capital Expenditures (2019 - 2025)
Pharming (PHAR) posted Capital Expenditures of -$749000.0 for Q4 2025, up 5.19% on a QoQ basis from -$790000.0 in Q4 2024, and up 5.19% year-over-year from -$712045.7 in Q4 2024.
Pharming (PHAR) Capital Expenditures (2019 - 2025) Analysis & Trends
Pharming's Capital Expenditures history runs 7 years deep, the most recent figure standing at -$749000.0 for Q4 2025.
- Quarterly Capital Expenditures rose 5.19% year-over-year to -$749000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.3 million (down 21.97% YoY) and the FY2025 annual result came in at $749000.0, down 6.37% from the prior year.
- Capital Expenditures was -$749000.0 for Q4 2025 at Pharming, up from -$790000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at -$147000.0 in Q3 2023 and bottomed at -$2.0 million in Q3 2021.
- A 5-year average of -$899994.0 and a median of -$769500.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2021 — Capital Expenditures tumbled 40148.79% — and 2022, when it jumped 89.37%.
- Pharming's Capital Expenditures stood at -$2.0 million in 2021, then soared by 89.37% to -$208000.0 in 2022, then plunged by 590.87% to -$1.4 million in 2023, then jumped by 45.02% to -$790000.0 in 2024, then gained by 5.19% to -$749000.0 in 2025.
- Business Quant data shows PHAR's Capital Expenditures at -$749000.0 in Q4 2025, -$790000.0 in Q4 2024, and -$366000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -749,000.00 |
| Dec 31, 2025 | -749,000.00 |
| Dec 31, 2024 | -790,000.00 |
| Dec 31, 2024 | -790,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Dec 31, 2023 | -1.44 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | -147,000.00 |
| Sep 30, 2023 | -147,000.00 |
| Jun 30, 2023 | -986,000.00 |
| Jun 30, 2023 | -986,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Sep 30, 2022 | -342,000.00 |
| Sep 30, 2022 | -342,000.00 |
| Dec 31, 2021 | -1.96 Mn |
| Dec 31, 2021 | -1.96 Mn |
| Sep 30, 2021 | -2.02 Mn |
| Sep 30, 2021 | -2.02 Mn |